In their new study, the LJI scientists are the first to show that GPR25 is induced by a signaling molecule called TGF-β.

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

The daily pill may provide a more convenient alternative to injections, which patients can find difficult to administer.

A new oral GLP-1 medication can help adults with obesity and Type 2 diabetes lose more weight and improve their blood sugar levels compared to a placebo, according to findings from the ATTAIN-2 trial ...

Listening to a favorite song can trigger a profound emotional response that rivals the feelings produced by biological ...